Results 101 to 110 of about 23,074,058 (199)

Haemorrhagic event reporting with concomitant gemcitabine and warfarin: a VigiBase disproportionality analysis. [PDF]

Front Pharmacol
Nishida K, Chrétien B, Da Silva A, Calabia A, Matsui S, Terada T, Ando Y.   +6 more
europepmc   +1 more source

Detection of Signals for Smell and Taste Disorders Associated with Z-drugs: A Disproportionality Analysis of the FAERS Database. [PDF]

Oral Health Prev Dent
Yang H, Liang Y, Wang H, Xu Q, Kou Z, Zou Y.   +5 more
europepmc   +1 more source

Semaglutide and Panic Attacks: Active-Comparator Disproportionality Analysis, Temporal Assessment of Notoriety Bias and Evidence Triangulation in Post-Marketing Pharmacovigilance. [PDF]

Pharmacoepidemiol Drug Saf
Melamed B, Parsi-Zahabi M, Omrani MA, Baskaran BS, Eddin LE, Kermanshahi N, Chalabianloo N, Muanda FT.   +7 more
europepmc   +1 more source

Ephedrae Herba-Associated Adverse Events: A Disproportionality Analysis Integrated with Network Pharmacology. [PDF]

Pharmaceuticals (Basel)
Park M, Shin HK, Choi Y.
europepmc   +1 more source

Disproportionality analysis to investigate fatal adverse events with immune checkpoint inhibitors: Proceed with extreme caution. [PDF]

Proc Natl Acad Sci U S A
Revol B, Khouri C, Raschi E.
europepmc   +1 more source

Temporal and disproportionality analysis of vaccine-associated Guillain-Barré syndrome: a 21-year VAERS study. [PDF]

Front Neurol
Su Y, Huang Y, Pan L, Fu H, Wang X.
europepmc   +1 more source

Disproportionality: The Impact Identifying Students for Special Education

This thesis focuses on the topic of disproportionality as it relates to the special education population. Disproportionality is an area of interest for this researcher, who wanted to explore and learn more about disproportionality, the true numbers ...
Bradford, John M
core   +1 more source

Post-marketing safety of ensifentrine in COPD: A retrospective pharmacovigilance study using disproportionality analysis of FAERS/AEMS reports. [PDF]

Medicine (Baltimore)
Yağbasan FÖ.
europepmc   +1 more source

Atorvastatin-associated neurological adverse events: a disproportionality analysis with adjustment for confounding by indication. [PDF]

Front Med (Lausanne)
He X, Zhou Q, Zhang M, Wang D, Xu X.
europepmc   +1 more source

Zolbetuximab-associated adverse event reporting signals in gastric cancer: a FAERS disproportionality analysis. [PDF]

Front Pharmacol
Zhang J, Zhen Z, Li Z, Zhu P.
europepmc   +1 more source